This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe
November 3–5, 2025
Vienna Congress and Convention Center, Vienna, AustriaNovember 11–12, 2025 | Digital Partnering

Viktoria Enkmann
CEO at RAR -RNAAnalytics Advanced Research GmbH
Speaker

Profile

Ing. Viktoria Maria Enkmann, MSc, MSc, MBA is the co-founder, CEO and CSO of RNAnalytics Advanced Research GmbH, where she leads the development of modular capillary electrophoresis-based analytical toolkits and AI-driven software for precise characterization of lipid nanoparticles in RNA therapeutics. Since founding the company in 2023, she has built an interdisciplinary team, secured pre-seed funding, and forged strategic partnerships with academic institutions. Prior to RNAnalytics, Viktoria held progressive roles at Sciex-expanding their biopharma division in the DACH region-and served in business development at Nuvisan and structural analytics leadership at Vela Labs, always focusing on GMP-compliant method development and data analysis. She holds an MBA from Donau-Universität Krems, MSc degrees in Biotechnology & Biomedicine from VetMedUni Vienna and in Tissue Engineering & Regenerative Medicine from FH Technikum Wien, as well as a BSc in Medicinal Chemistry from Dublin Institute of Technology.